Day-to-Day Impact of Vaginal Aging questionnaire: a multidimensional measure of the impact of vaginal symptoms on functioning and well-being in postmenopausal women - PubMed (original) (raw)
Day-to-Day Impact of Vaginal Aging questionnaire: a multidimensional measure of the impact of vaginal symptoms on functioning and well-being in postmenopausal women
Alison J Huang et al. Menopause. 2015 Feb.
Abstract
Objective: This study aims to develop a self-report questionnaire assessing the impact of vaginal dryness, soreness, itching, irritation, and pain on functioning and well-being in postmenopausal women.
Methods: Structured self-report items were developed to address the impact of vaginal symptoms on functioning and well-being based on findings from focus groups with racially/ethnically diverse, symptomatic postmenopausal women. Items were refined after cognitive interview pretesting and field-tested among symptomatic postmenopausal women enrolled in a multiethnic cohort study in California. Exploratory factor analysis (SAS PROC VARCLUS) and confirmatory factor analysis evaluated factor structure and eliminated poorly fitting items. Additional evidence of construct validity was obtained via examination of correlations with other measures of related constructs. Internal consistency and test-retest reliability were assessed using Cronbach α and correlation coefficients, respectively.
Results: For the 745 postmenopausal women who completed the draft questionnaire, the mean (SD) age was 56.2 (8.5) years, and 66% of the respondents were racial/ethnic minorities. The refined questionnaire included four multi-item scales addressing symptom impact on (1) activities of daily living, (2) emotional well-being, (3) sexual functioning, and (4) self-concept and body image. The four-factor model provided good approximate fit (comparative fit index, 0.987; standardized root-mean-square residual, 0.038). Correlations with other measures of symptom bothersomeness, sexual function, depression, and anxiety conformed to hypotheses. Cronbach α values ranged from 0.82 to 0.93. Intraclass coefficients ranged from 0.47 to 0.72.
Conclusions: The Day-to-Day Impact of Vaginal Aging questionnaire is a new multidimensional self-report measure designed to facilitate evaluation of the impact of vaginal symptoms on postmenopausal women of diverse backgrounds.
Conflict of interest statement
Conflicts of interest: Dr. Huang has received grant funding from Pfizer, Inc. to conduct other research on vaginal symptoms. Dr. Brown has received funding from Pfizer, Inc. to conduct research unrelated to vaginal symptoms. No other potential conflicts of interest are noted.
Comment in
- Vaginal health prescription: possible next step in the management of genitourinary syndrome of menopause.
Bachmann GA, Phillips NA. Bachmann GA, et al. Menopause. 2015 Feb;22(2):127-8. doi: 10.1097/GME.0000000000000414. Menopause. 2015. PMID: 25549067 No abstract available.
References
- Pastore LM, Carter RA, Hulka BS, Wells E. Self-reported urogenital symptoms in postmenopausal women: Women's Health Initiative. Maturitas. 2004 Dec 10;49(4):292–303. -PubMed
- Huang AJ, Grady D, Jacoby VL, Blackwell TL, Bauer DC, Sawaya GF. Persistent hot flushes in older postmenopausal women. Arch Intern Med. 2008 Apr 28;168(8):840–846. -PubMed
- Barnabei VM, Grady D, Stovall DW, et al. Menopausal symptoms in older women and the effects of treatment with hormone therapy. Obstet Gynecol. 2002 Dec;100(6):1209–1218. -PubMed
- Gupta P, Ozel B, Stanczyk FZ, Felix JC, Mishell DR., Jr The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status. Menopause. 2008 Jan-Feb;15(1):94–97. -PubMed
Publication types
MeSH terms
Grants and funding
- P30 MH062246/MH/NIMH NIH HHS/United States
- P30 AG15272/AG/NIA NIH HHS/United States
- P50 DK064538/DK/NIDDK NIH HHS/United States
- P30 AG015272/AG/NIA NIH HHS/United States
- R03 AG035207/AG/NIA NIH HHS/United States
- P30 AG044281/AG/NIA NIH HHS/United States
- K23 AG038335/AG/NIA NIH HHS/United States
- K24 AG041180/AG/NIA NIH HHS/United States
- 1R03AG035207/AG/NIA NIH HHS/United States
- 1K23AG038335/AG/NIA NIH HHS/United States